Why bluebird bio Inc. (BLUE)’s Most Recent Report Reveals Some Hints About Its Future

 3 hours ago Siraj

bluebird bio Inc. (NASDAQ:BLUE) went up by 0.85% from its latest closing price compared to the recent 1-year high of $17.85. The company’s stock price has collected -0.28% of loss in the last five trading sessions. The Wall Street Journal reported on 08/17/22 that FDA Approves Bluebird’s Gene Therapy for Rare Blood Disease reed moor